CAMBRIDGE, MA-BioMed Realty Trust Inc. has completed the acquisition of 320 Charles St. here in a deal valued at $52 million, or $523 per square foot. The San Diego-based life sciences REIT did not identify the seller; industry data indicate it was Joseph Matzcam.

One hundred percent leased to the Whitehead Institute for BioMedical Research, 320 Charles comprises about 99,500 square feet of laboratory and office space. In connection with the acquisition, BioMed issued 2,034,211 operating partnership units in BioMed Realty L.P. to the seller, with the $8-million balance of the purchase price paid in cash, industry data show.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Dig Deeper

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.